President Donald Trump dismissed the idea of pardoning jailed cryptocurrency fraudster Sam Bankman-Fried, according to a ...
Arrowhead Pharmaceuticals, a leader in RNAi therapeutics, reported a significant insider sale amid a year of exceptional stock gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback